Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype

Cancer Letters

Volumn 310, Issue 1, 2011, Pages 46-52

  Yang, Lang ^a   Ping, Yi Fang ^a   Yu, Xi ^a   Qian, Feng ^a   Guo, Zheng Jun ^a   Qian, Cheng ^a   Cui, You Hong ^a   Bian, Xiu Wu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cells; Gastric cancer; Invasion; Sphere forming cells

Indexed keywords

GELATINASE A; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CANCER STEM LIKE CELL; CARCINOGENICITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ANIMALS; BLOTTING, WESTERN; CADHERINS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MULTIPOTENT STEM CELLS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 79961126637     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.003     Document Type: Article

References (42)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA. Cancer J. Clin. 2005, 55:74-108.
2. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., Wahl G.M. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006, 66:9339-9344.
3. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
4. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100:3983-3988.
5. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
6. Yu S.C., Ping Y.F., Yi L., Zhou Z.H., Chen J.H., Yao X.H., Gao L., Wang J.M., Bian X.W. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 2008, 265:124-134.
7. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Annu. Rev. Med. 2007, 58:267-284.
8. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
9. Cheng L., Bao S., Rich J.N. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem. Pharmacol. 2010, 80:654-665.
10. Fukuda K., Saikawa Y., Ohashi M., Kumagai K., Kitajima M., Okano H., Matsuzaki Y., Kitagawa Y. Tumor initiating potential of side population cells in human gastric cancer. Int. J. Oncol. 2009, 34:1201-1207.
11. Nishii T., Yashiro M., Shinto O., Sawada T., Ohira M., Hirakawa K. Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci. 2009, 100:1397-1402.
12. Takaishi S., Okumura T., Tu S., Wang S.S., Shibata W., Vigneshwaran R., Gordon S.A., Shimada Y., Wang T.C. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-1020.
13. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
14. Zhou Y., Bian X., Le Y., Gong W., Hu J., Zhang X., Wang L., Iribarren P., Salcedo R., Howard O.M., Farrar W., Wang J.M. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J. Natl. Cancer Inst. 2005, 97:823-835.
15. Chen D.L., Ping Y.F., Yu S.C., Chen J.H., Yao X.H., Jiang X.F., Zhang H.R., Wang Q.L., Bian X.W. Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells. Biochem. Biophys. Res. Commun. 2009, 381:448-452.
16. Yilmaz M., Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis. Rev. 2009, 28:15-33.
17. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell. 2008, 14:818-829.
18. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
19. Iwatsuki M., Mimori K., Fukagawa T., Ishii H., Yokobori T., Sasako M., Baba H., Mori M. The clinical significance of vimentin-expressing gastric cancer cells in bone marrow. Ann. Surg. Oncol. 2010, 17:2526-2533.
20. Kim M.A., Lee H.S., Lee H.E., Kim J.H., Yang H.K., Kim W.H. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology 2009, 54:442-451.
21. Fuyuhiro Y., Yashiro M., Noda S., Kashiwagi S., Matsuoka J., Doi Y., Kato Y., Kubo N., Ohira M., Hirakawa K. Clinical significance of vimentin-positive gastric cancer cells. Anticancer Res. 2010, 30:5239-5243.
22. Zhong X.Y., Zhang L.H., Jia S.Q., Shi T., Niu Z.J., Du H., Zhang G.G., Hu Y., Lu A.P., Li J.Y., Ji J.F. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer. Histopathology 2008, 52:560-568.
23. Santisteban M., Reiman J.M., Asiedu M.K., Behrens M.D., Nassar A., Kalli K.R., Haluska P., Ingle J.N., Hartmann L.C., Manjili M.H., Radisky D.C., Ferrone S., Knutson K.L. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res. 2009, 69:2887-2895.
24. Morel A.P., Lievre M., Thomas C., Hinkal G., Ansieau S., Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3:e2888.
25. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
26. Yu S.C., Bian X.W. Enrichment of cancer stem cells based on heterogeneity of invasiveness. Stem Cell. Rev. 2009, 5:66-71.
27. Roy R., Yang J., Moses M.A. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 2009, 27:5287-5297.
28. Chu D., Zhang Z., Li Y., Zheng J., Dong G., Wang W., Ji G. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int. J. Cancer 2010.
29. Mrena J., Wiksten J.P., Nordling S., Kokkola A., Ristimaki A., Haglund C. MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer. J. Clin. Pathol. 2006, 59:618-623.
30. Sun W.H., Sun Y.L., Fang R.N., Shao Y., Xu H.C., Xue Q.P., Ding G.X., Cheng Y.L. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn. J. Clin. Oncol. 2005, 35:707-713.
31. Zhang S., Li L., Lin J.Y., Lin H. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J. Gastroenterol. 2003, 9:899-904.
32. Wu Z.Y., Li J.H., Zhan W.H., He Y.L. Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma. World J. Gastroenterol. 2006, 12:2941-2944.
33. Campos B., Wan F., Farhadi M., Ernst A., Zeppernick F., Tagscherer K.E., Ahmadi R., Lohr J., Dictus C., Gdynia G., Combs S.E., Goidts V., Helmke B.M., Eckstein V., Roth W., Beckhove P., Lichter P., Unterberg A., Radlwimmer B., Herold-Mende C. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin. Cancer Res. 2010, 16:2715-2728.
34. Burkert J., Otto W.R., Wright N.A. Side populations of gastrointestinal cancers are not enriched in stem cells. J. Pathol. 2008, 214:564-573.
35. Ghods A.J., Irvin D., Liu G., Yuan X., Abdulkadir I.R., Tunici P., Konda B., Wachsmann-Hogiu S., Black K.L., Yu J.S. Spheres isolated from 9L gliosarcoma rat cell line possess chemoresistant and aggressive cancer stem-like cells. Stem Cells 2007, 25:1645-1653.
36. Di Fiore R., Santulli A., Ferrante R.D., Giuliano M., De Blasio A., Messina C., Pirozzi G., Tirino V., Tesoriere G., Vento R. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. J. Cell. Physiol. 2009, 219:301-313.
37. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., Van Belle P.A., Xu X., Elder D.E., Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 2005, 65:9328-9337.
38. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15:504-514.
39. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., Daidone M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005, 65:5506-5511.
40. Yuan X., Curtin J., Xiong Y., Liu G., Waschsmann-Hogiu S., Farkas D.L., Black K.L., Yu J.S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23:9392-9400.
41. Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., Sciacca F.L., Ottolina A., Parati E.A., La Porta C., Alessandri G., Marras C., Croci D., De Rossi M. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006, 54:850-860.
42. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell R., Bayani J., Head R., Lee M., Bernstein M., Squire J.A., Smith A., Dirks P. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4:568-580.